Attempt to Substitute the Oncotype DX Breast Recurrence Score® Test by Histopathological Factors and MUC1 Protein Expression
2024 · Cancer Diagnosis & Prognosis · 5 citations
https://doi.org/10.21873/cdp.10349
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
9
Papers
15
Citations
3
h-index
0
i10-index
Yoshiya Horimoto is an academic researcher from Tokyo Medical University. The author has contributed to research in topics: Breast Cancer Treatment Studies & Health Literacy and Information Accessibility & HER2/EGFR in Cancer Research. The author has an h-index of 3, co-authored 8 publications.
Click to start Chat